http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2195957-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04e47baeb0c78e78b4125a065c2c56b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b88fce427f830c1d83d03138b4bb825
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
filingDate 2000-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2003-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_015ac06548dc812f968f1d6415f33b4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18a175cb7c02d46d7a8f3b4e659dd49a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a58bf4ba02dcd5f492d8b45c070ecab
publicationDate 2003-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2195957-C2
titleOfInvention Method for treating negative disorders in case of schizophrenia
abstract FIELD: medicine, psychiatry. SUBSTANCE: therapy by using psychotropic preparations should be supplemented with 0.005%- imunophane solution at 1 ml dosage intramuscularly daily for 15 d. The method enables to shorten therapy course and decrease the number of complications. EFFECT: higher efficiency of therapy. 1 ex
priorityDate 2000-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3559
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398737
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5073
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414856084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507434
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID352907

Total number of triples: 24.